Clinical Trial Update: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of octreotide subcutaneous depot in patients with gastroenteropancreatic neuroendocrine tumors, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• Octreotide Subcutaneous Depot (octreotide)

Snippet

Sponsor: Camurus AB | Conditions: Gastro-enteropancreatic Neuroendocrine Tumor | Phase 3 | Status: ACTIVE_NOT_RECRUITING